153 related articles for article (PubMed ID: 15487766)
1. A report of high-dose selenium supplementation: response and toxicities.
Reid ME; Stratton MS; Lillico AJ; Fakih M; Natarajan R; Clark LC; Marshall JR
J Trace Elem Med Biol; 2004; 18(1):69-74. PubMed ID: 15487766
[TBL] [Abstract][Full Text] [Related]
2. Response of selenium status indicators to supplementation of healthy North American men with high-selenium yeast.
Hawkes WC; Richter BD; Alkan Z; Souza EC; Derricote M; Mackey BE; Bonnel EL
Biol Trace Elem Res; 2008 May; 122(2):107-21. PubMed ID: 18193397
[TBL] [Abstract][Full Text] [Related]
3. Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.
Algotar AM; Stratton MS; Ahmann FR; Ranger-Moore J; Nagle RB; Thompson PA; Slate E; Hsu CH; Dalkin BL; Sindhwani P; Holmes MA; Tuckey JA; Graham DL; Parnes HL; Clark LC; Stratton SP
Prostate; 2013 Feb; 73(3):328-35. PubMed ID: 22887343
[TBL] [Abstract][Full Text] [Related]
4. Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial.
Hurwitz BE; Klaus JR; Llabre MM; Gonzalez A; Lawrence PJ; Maher KJ; Greeson JM; Baum MK; Shor-Posner G; Skyler JS; Schneiderman N
Arch Intern Med; 2007 Jan; 167(2):148-54. PubMed ID: 17242315
[TBL] [Abstract][Full Text] [Related]
5. Effect of supplementation with Se-enriched yeast and factors influencing Se concentration in plasma of transplant recipients.
Bost M; Blouin E
J Trace Elem Med Biol; 2009; 23(1):36-42. PubMed ID: 19203715
[TBL] [Abstract][Full Text] [Related]
6. Influence of selenium-enriched yeast supplementation on biomarkers of oxidative damage and hormone status in healthy adult males: a clinical pilot study.
El-Bayoumy K; Richie JP; Boyiri T; Komninou D; Prokopczyk B; Trushin N; Kleinman W; Cox J; Pittman B; Colosimo S
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1459-65. PubMed ID: 12433727
[TBL] [Abstract][Full Text] [Related]
7. Acute and subchronic toxicity studies on Sel-Plex, a standardized, registered high-selenium yeast.
Griffiths JC; Matulka RA; Power R
Int J Toxicol; 2006; 25(6):465-76. PubMed ID: 17132605
[TBL] [Abstract][Full Text] [Related]
8. Impact of selenium on mood and quality of life: a randomized, controlled trial.
Rayman M; Thompson A; Warren-Perry M; Galassini R; Catterick J; Hall E; Lawrence D; Bliss J
Biol Psychiatry; 2006 Jan; 59(2):147-54. PubMed ID: 16181615
[TBL] [Abstract][Full Text] [Related]
9. The nutritional prevention of cancer: 400 mcg per day selenium treatment.
Reid ME; Duffield-Lillico AJ; Slate E; Natarajan N; Turnbull B; Jacobs E; Combs GF; Alberts DS; Clark LC; Marshall JR
Nutr Cancer; 2008; 60(2):155-63. PubMed ID: 18444146
[TBL] [Abstract][Full Text] [Related]
10. A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancer.
Chi KN; Gleave ME; Klasa R; Murray N; Bryce C; Lopes de Menezes DE; D'Aloisio S; Tolcher AW
Clin Cancer Res; 2001 Dec; 7(12):3920-7. PubMed ID: 11751483
[TBL] [Abstract][Full Text] [Related]
11. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial.
Duffield-Lillico AJ; Reid ME; Turnbull BW; Combs GF; Slate EH; Fischbach LA; Marshall JR; Clark LC
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):630-9. PubMed ID: 12101110
[TBL] [Abstract][Full Text] [Related]
12. Prostatic and peripheral blood selenium levels after oral supplementation.
Gianduzzo TR; Holmes EG; Tinggi U; Shahin M; Mactaggart P; Nicol D
J Urol; 2003 Sep; 170(3):870-3. PubMed ID: 12913719
[TBL] [Abstract][Full Text] [Related]
13. Oral selenium supplementation has no effect on prostate-specific antigen velocity in men undergoing active surveillance for localized prostate cancer.
Stratton MS; Algotar AM; Ranger-Moore J; Stratton SP; Slate EH; Hsu CH; Thompson PA; Clark LC; Ahmann FR
Cancer Prev Res (Phila); 2010 Aug; 3(8):1035-43. PubMed ID: 20647337
[TBL] [Abstract][Full Text] [Related]
14. Effect of selenium supplementation on biochemical markers and outcome in critically ill patients.
Mishra V; Baines M; Perry SE; McLaughlin PJ; Carson J; Wenstone R; Shenkin A
Clin Nutr; 2007 Feb; 26(1):41-50. PubMed ID: 17174015
[TBL] [Abstract][Full Text] [Related]
15. High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma.
Morris MJ; Smaletz O; Solit D; Kelly WK; Slovin S; Flombaum C; Curley T; Delacruz A; Schwartz L; Fleisher M; Zhu A; Diani M; Fallon M; Scher HI
Cancer; 2004 May; 100(9):1868-75. PubMed ID: 15112267
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
17. Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the 'Watchful Waiting' Study.
Stratton MS; Reid ME; Schwartzberg G; Minter FE; Monroe BK; Alberts DS; Marshall JR; Ahmann FR
Anticancer Drugs; 2003 Sep; 14(8):595-600. PubMed ID: 14501381
[TBL] [Abstract][Full Text] [Related]
18. Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial.
Reid ME; Duffield-Lillico AJ; Garland L; Turnbull BW; Clark LC; Marshall JR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1285-91. PubMed ID: 12433704
[TBL] [Abstract][Full Text] [Related]
19. Long-term selenium supplementation of humans: selenium status and relationships between selenium concentrations in skeletal muscle and indicator materials.
Behne D; Alber D; Kyriakopoulos A
J Trace Elem Med Biol; 2010 Apr; 24(2):99-105. PubMed ID: 20413067
[TBL] [Abstract][Full Text] [Related]
20. Diethylstilboestrol versus bicalutamide in hormone refractory prostate carcinoma: a prospective randomized trial.
Manikandan R; Srirangam SJ; Pearson E; Brown SC; O'Reilly P; Collins GN
Urol Int; 2005; 75(3):217-21. PubMed ID: 16215308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
